Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Neema Mturi
Daily Co-Trimoxazole Prophylaxis to Prevent Mortality in Children With Complicated Severe Acute Malnutrition: A Multicentre, Double-Blind, Randomised Placebo-Controlled Trial
The Lancet Global Health
Medicine
Should First-Line Empiric Treatment Strategies Cover Coagulase-Negative Staphylococcal Infections in Severely Malnourished or HIV-infected Children in Kenya?
PLoS ONE
Multidisciplinary
Related publications
Probiotic Prophylaxis in Patients With Predicted Severe Acute Pancreatitis (PROPATRIA): Design and Rationale of a Double-Blind, Placebo-Controlled Randomised Multicenter Trial [ISRCTN38327949]
BMC Surgery
Medicine
Surgery
Acyclovir Given as Prophylaxis Against Oral Ulcers in Acute Myeloid Leukaemia: Randomised, Double Blind, Placebo Controlled Trial
BMJ
Aspirin for Prophylaxis Against Headache at High Altitudes: Randomised, Double Blind, Placebo Controlled Trial
BMJ
Antibiotic Treatment for 6 Days Versus 12 Days in Patients With Severe Cellulitis: A Multicentre Randomised, Double-Blind, Placebo-Controlled, Non-Inferiority Trial
Clinical Microbiology and Infection
Medicine
Infectious Diseases
Microbiology
Diclofenac Patch for Topical Treatment of Acute Impact Injuries: A Randomised, Double Blind, Placebo Controlled, Multicentre Study
British Journal of Sports Medicine
Sports Medicine
Physical Therapy
Sports Science
Sports Therapy
Orthopedics
Medicine
Rehabilitation
Randomised, Double-Blind, Placebo-Controlled Trial of EPs 7630 in Adults With COPD
Respiratory Medicine
Pulmonary
Respiratory Medicine
Bushenjianpi Formula Combined With Entecavir for HBeAg-negative Chronic Hepatitis B Patients: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial
The Lancet
Medicine
Oral Magnesium Oxide Prophylaxis of Frequent Migrainous Headache in Children: A Randomized, Double-Blind, Placebo-Controlled Trial
Headache
Neurology
A Randomized, Double-Blind, Placebo-Controlled Trial of Valacyclovir Prophylaxis to Prevent Zoster Recurrence From Months 4 to 24 After BMT
Bone Marrow Transplantation
Transplantation
Hematology
